BaFin Applies Future ESMA Guidelines on Product Supplements to Base Prospectuses Early
BaFin is already applying ESMA's forthcoming guidelines on when a supplement to a base prospectus amounts to an impermissible introduction of a new type of security, and it is abandoning its previous administrative practice on product-modifying supplements. Compliance and capital markets teams at issuers of base prospectuses should align their supplement preparation and review processes now, rather than waiting for the formal application date.


